142 related articles for article (PubMed ID: 38281385)
21. Assessing Molecular Point-of-Care Testing and Dried Blood Spot for Hepatitis C Virus Screening in People Who Inject Drugs.
Chevaliez S; Wlassow M; Volant J; Roudot-Thoraval F; Bachelard A; Poiteau L; Trabut JB; Hézode C; Bourdel A; Dominguez S
Open Forum Infect Dis; 2020 Jun; 7(6):ofaa196. PubMed ID: 32617372
[TBL] [Abstract][Full Text] [Related]
22. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.
Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A
Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752
[TBL] [Abstract][Full Text] [Related]
23. In-field evaluation of Xpert® HCV viral load Fingerstick assay in people who inject drugs in Tanzania.
Mohamed Z; Mbwambo J; Rwegasha J; Mgina N; Doulla B; Mwakale P; Tuaillon E; Chevaliez S; Shimakawa Y; Taylor-Robinson SD; Thursz MR; Brown AS; Lemoine M
Liver Int; 2020 Mar; 40(3):514-521. PubMed ID: 31778282
[TBL] [Abstract][Full Text] [Related]
24. Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers.
Fontaine G; Presseau J; Bruneau J; Etherington C; Thomas IM; Hung JC; van Allen Z; Patey AM; Kareem A; Mortazhejri S; Høj SB; Boyer-Legault G; Grimshaw JM
Int J Equity Health; 2024 Jun; 23(1):124. PubMed ID: 38886803
[TBL] [Abstract][Full Text] [Related]
25. Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study.
Passos-Castilho AM; Murphy DG; Blouin K; Benedetti A; Panagiotoglou D; Bruneau J; Klein MB; Kwong JC; Sander B; Janjua NZ; Greenaway C
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543755
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.
Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ
J Viral Hepat; 2019 Aug; 26(8):969-979. PubMed ID: 30980785
[TBL] [Abstract][Full Text] [Related]
27. Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis.
Trickey A; Fajardo E; Alemu D; Artenie AA; Easterbrook P
Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):253-270. PubMed ID: 36706775
[TBL] [Abstract][Full Text] [Related]
28. A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment.
Seaman A; King CA; Kaser T; Geduldig A; Ronan W; Cook R; Chan B; Levander XA; Priest KC; Korthuis PT
Int J Drug Policy; 2021 Oct; 96():103359. PubMed ID: 34325969
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ;
J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of the CT2 study: A 'one-stop-shop' for community-based hepatitis C testing and treatment in Yangon, Myanmar.
Draper BL; Htay H; Pedrana A; Yee WL; Howell J; Pyone Kyi K; Naing W; Sanda Aung K; Markby J; Easterbrook P; Bowring A; Aung W; Sein YY; Nwe N; Myint KT; Shilton S; Hellard M
Liver Int; 2021 Nov; 41(11):2578-2589. PubMed ID: 34153155
[TBL] [Abstract][Full Text] [Related]
31. An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study.
Alavi M; Poustchi H; Merat S; Kaveh-Ei S; Rahimi-Movaghar A; Shadloo B; Hajarizadeh B; Grebely J; Dore GJ; Malekzadeh R
Int J Drug Policy; 2019 Oct; 72():99-105. PubMed ID: 31303262
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a Project Integrating Financial Incentives into a Hepatitis C Testing and Treatment Model of Care at a Sexual Health Service in Cairns, Australia, 2020-2021.
Dawe J; Gorton C; Lewis R; Richmond JA; Wilkinson AL; Pedrana A; Stoové M; Doyle JS; Russell D
Viruses; 2024 May; 16(5):. PubMed ID: 38793681
[TBL] [Abstract][Full Text] [Related]
33. Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.
Valerio H; Conway A; Alavi M; Treloar C; Silk D; Murray C; Henderson C; Amin J; Read P; Degenhardt L; Christmass M; Montebello M; Dore GJ; Grebely J;
Int J Drug Policy; 2022 Dec; 110():103876. PubMed ID: 36240657
[TBL] [Abstract][Full Text] [Related]
34. Treating people where they are: Nurse-led micro-elimination of hepatitis C in supported housing sites for networks of people who inject drugs in Victoria, Canada.
Selfridge M; Barnett T; Lundgren K; Guarasci K; Milne R; Drost A; Fraser C
Public Health Nurs; 2022 Sep; 39(5):1009-1016. PubMed ID: 35537120
[TBL] [Abstract][Full Text] [Related]
35. The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study.
Howell J; Traeger MW; Williams B; Layton C; Doyle JS; Latham N; Draper B; Bramwell F; Membrey D; McPherson M; Roney J; Stoové M; Thompson AJ; Hellard ME; Pedrana A
J Viral Hepat; 2022 May; 29(5):375-384. PubMed ID: 35274403
[TBL] [Abstract][Full Text] [Related]
36. Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world data.
Palmateer NE; McAuley A; Dillon JF; McDonald S; Yeung A; Smith S; Barclay S; Hayes P; Shepherd SJ; Gunson RN; Goldberg DJ; Hickman M; Hutchinson SJ
Addiction; 2021 Oct; 116(10):2893-2907. PubMed ID: 33651446
[TBL] [Abstract][Full Text] [Related]
37. ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in Austria.
Schwarz C; Bauer D; Dorn L; Jachs M; Hartl L; Chromy D; Weseslindtner L; Pfisterer N; Hennlich B; Stückler A; Strassl R; Voill-Glaninger A; Hübl W; Willheim M; Köhrer K; Jansen-Skoupy S; Tomez S; Krugluger W; Madl C; Schwarz M; Balcar L; Semmler G; Brinkmann L; Burghart L; Antonitsch L; Weidinger G; Riedl F; Laferl H; Kurteva V; Traugott M; Hind J; Wenisch C; Aburaia A; Sebesta C; Schmid D; Rothweiler S; Remetic J; Gschwantler M; Maieron A; Reiberger T
Wien Klin Wochenschr; 2024 May; 136(9-10):278-288. PubMed ID: 37773541
[TBL] [Abstract][Full Text] [Related]
38. Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three-arm study.
Shilton S; Markby J; Japaridze M; Chihota V; Shadaker S; Gvinjilia L; Tsereteli M; Alkhazashvili M; Butsashvili M; Stvilia K; Ruiz RJ; Asatiani A; Adamia E; Easterbrook P; Khonelidze I; Gamkrelidze A
Liver Int; 2022 Apr; 42(4):775-786. PubMed ID: 35129278
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study.
Hobday S; Valerio H; Combo T; Monaghan R; Scott C; Silk D; Murray C; Read P; Henderson C; Degenhardt L; Treloar C; Dore GJ; Grebely J; Martinello M;
Drug Alcohol Rev; 2023 Nov; 42(7):1617-1632. PubMed ID: 37556376
[TBL] [Abstract][Full Text] [Related]
40. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
